Hawkins (HWKN) Expected to Post Earnings on Monday

Hawkins (NASDAQ:HWKN) is anticipated to release its Q2 2027 results after the market closes on Monday, October 26th. Analysts expect Hawkins to announce earnings of $1.19 per share and revenue of $302.70 million for the quarter. Parties may review the information on the company’s upcoming Q2 2027 earnings overview page for the latest details on the call scheduled for Monday, October 26, 2026 at 4:10 PM ET.

Hawkins (NASDAQ:HWKN) last released its earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share for the quarter, missing analysts’ consensus estimates of $1.39 by ($0.04). The business had revenue of $315.68 million during the quarter, compared to analysts’ expectations of $313.42 million. Hawkins had a return on equity of 15.42% and a net margin of 7.29%. On average, analysts expect Hawkins to post $4.07 EPS for the current fiscal year and $4.80 EPS for the next fiscal year.

Hawkins Stock Down 0.6%

Shares of NASDAQ:HWKN opened at $132.32 on Friday. The stock has a fifty day simple moving average of $126.32 and a two-hundred day simple moving average of $141.85. The company has a current ratio of 2.27, a quick ratio of 1.54 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $2.76 billion, a price-to-earnings ratio of 34.28, a PEG ratio of 2.71 and a beta of 0.74. Hawkins has a 12-month low of $116.04 and a 12-month high of $174.12.

Hawkins Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 28th. Investors of record on Friday, August 14th were issued a $0.19 dividend. The ex-dividend date was Friday, August 14th. This represents a $0.76 annualized dividend and a yield of 0.6%. Hawkins’s dividend payout ratio (DPR) is currently 20.73%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HWKN. BWS Financial reissued a “buy” rating and set a $200.00 price objective on shares of Hawkins in a research report on Monday, August 3rd. Zacks Research cut Hawkins from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 4th. Weiss Ratings upgraded Hawkins from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, September 21st. Finally, Barclays set a $141.00 price target on Hawkins and gave the company an “equal weight” rating in a report on Tuesday, October 13th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $170.50.

Insiders Place Their Bets

In related news, CFO Jeffrey Oldenkamp purchased 1,290 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The stock was bought at an average price of $119.00 per share, for a total transaction of $153,510.00. Following the completion of the transaction, the chief financial officer owned 104,223 shares in the company, valued at approximately $12,402,537. The trade was a 1.25% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Douglas Lange bought 910 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were bought at an average cost of $118.75 per share, for a total transaction of $108,062.50. Following the transaction, the vice president owned 28,169 shares in the company, valued at approximately $3,345,068.75. The trade was a 3.34% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 3.70% of the company’s stock.

About Hawkins

Hawkins, Inc (NASDAQ:HWKN) is a chemical manufacturer, blender and distributor serving customers across the United States. The company supplies a range of water treatment chemicals, industrial chemicals and specialty products to municipal, commercial and industrial users.

Its water treatment business provides chemicals and related solutions used in drinking water, wastewater and industrial water treatment applications. Hawkins also serves the industrial, health and nutrition, and specialty chemical markets, offering products such as chemical blends, custom formulations and other materials used in manufacturing, agriculture, food processing and pharmaceutical applications.

Founded in 1938, Hawkins is headquartered in Roseville, Minnesota, and operates through a network of manufacturing, blending, distribution and sales locations in the United States.